New York bills · 2025 Regular Session
New York A 1647
Relates to decriminalizing the possession of buprenorphine
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Linda Rosenthal (Democratic)
Cosponsors (20)
- Jeffrey Dinowitz (Democratic)
- Jo Anne Simon (Democratic)
- Karines Reyes (Democratic)
- Phil Steck (Democratic)
- Jessica Gonzalez-Rojas (Democratic/Working Families)
- Chris Burdick (Democratic/Independence/Working Families)
- Zohran Mamdani
- Phara Souffrant Forrest (Democratic)
- Andrew Hevesi (Democratic)
- Catalina Cruz (Democratic)
- Sarah Clark (Democratic/Working Families)
- Emily Gallagher (Democratic)
- Al Taylor (Democratic)
- David Weprin (Democratic)
- Latrice Walker (Democratic)
- Sarahana Shrestha (Democratic/Working Families)
- Maritza Davila (Democratic)
- Marcela Mitaynes (Democratic/Working Families)
- Rodneyse Bichotte Hermelyn (Democratic)
- Harvey Epstein
Summary
Official abstract published by the New York legislature
Decriminalizes the possession of buprenorphine from certain crimes.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 8, 2026 · House
AMEND BY RESTORING TO ORIGINAL PRINT 1647 - Jan 7, 2026 · House
REFERRED TO CODES - Jun 6, 2025 · House
PRINT NUMBER 1647A - Jun 6, 2025 · House
AMEND AND RECOMMIT TO CODES - Jan 10, 2025 · House
REFERRED TO CODES